 Hypertension, Pulmonary
"Hypertension, Pulmonary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Descriptor ID |
D006976
|
| MeSH Number(s) |
C08.381.423
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypertension, Pulmonary".
Below are MeSH descriptors whose meaning is more specific than "Hypertension, Pulmonary".
This graph shows the total number of publications written about "Hypertension, Pulmonary" by people in this website by year, and whether "Hypertension, Pulmonary" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 4 | 0 | 4 | | 1994 | 8 | 2 | 10 | | 1995 | 9 | 1 | 10 | | 1996 | 12 | 3 | 15 | | 1997 | 11 | 2 | 13 | | 1998 | 21 | 2 | 23 | | 1999 | 15 | 1 | 16 | | 2000 | 9 | 2 | 11 | | 2001 | 7 | 1 | 8 | | 2002 | 16 | 3 | 19 | | 2003 | 15 | 4 | 19 | | 2004 | 25 | 3 | 28 | | 2005 | 35 | 4 | 39 | | 2006 | 21 | 5 | 26 | | 2007 | 23 | 4 | 27 | | 2008 | 24 | 4 | 28 | | 2009 | 32 | 2 | 34 | | 2010 | 28 | 6 | 34 | | 2011 | 32 | 8 | 40 | | 2012 | 35 | 7 | 42 | | 2013 | 42 | 5 | 47 | | 2014 | 38 | 4 | 42 | | 2015 | 46 | 6 | 52 | | 2016 | 45 | 3 | 48 | | 2017 | 37 | 4 | 41 | | 2018 | 29 | 2 | 31 | | 2019 | 36 | 3 | 39 | | 2020 | 36 | 3 | 39 | | 2021 | 35 | 0 | 35 | | 2022 | 31 | 1 | 32 | | 2023 | 6 | 1 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypertension, Pulmonary" by people in Profiles.
-
Kumar R, Lee MH, Kassa B, Fonseca Balladares DC, Mickael C, Sanders L, Andruska A, Kumar M, Spiekerkoetter E, Bandeira A, Stenmark KR, Tuder RM, Graham BB. Repetitive schistosoma exposure causes perivascular lung fibrosis and persistent pulmonary hypertension. Clin Sci (Lond). 2023 04 26; 137(8):617-631.
-
Brown RD, Hunter KS, Li M, Frid MG, Harral J, Krafsur GM, Holt TN, Williams J, Zhang H, Riddle SR, Edwards MG, Kumar S, Hu CJ, Graham BB, Walker LA, Garry FB, Buttrick PM, Lahm T, Kheyfets VO, Hansen KC, Stenmark KR. Functional and molecular determinants of right ventricular response to severe pulmonary hypertension in a large animal model. Am J Physiol Heart Circ Physiol. 2023 06 01; 324(6):H804-H820.
-
Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Gr?nig E, Kopec G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2023 Apr 20; 388(16):1478-1490.
-
Zhang H, D'Alessandro A, Li M, Reisz JA, Riddle S, Muralidhar A, Bull T, Zhao L, Gerasimovskaya E, Stenmark KR. Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension. Vascul Pharmacol. 2023 04; 149:107157.
-
Edward J, Banchs J, Parker H, Cornwell W. Right ventricular function across the spectrum of health and disease. Heart. 2023 02 14; 109(5):349-355.
-
Brown CE, Steiner JM, Modes M, Lynch Y, Leary PJ, Curtis JR, Engelberg RA. Palliative Care Perspectives of Patients with Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2023 02; 20(2):331-334.
-
Gu S, Goel K, Forbes LM, Kheyfets VO, Yu YA, Tuder RM, Stenmark KR. Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension. Compr Physiol. 2023 01 30; 13(1):4295-4319.
-
Davis-Hall D, Thomas E, Pe?a B, Magin CM. 3D-bioprinted, phototunable hydrogel models for studying adventitial fibroblast activation in pulmonary arterial hypertension. Biofabrication. 2022 12 19; 15(1).
-
Chandrasekara S, Lau EM, Anderson J, Collins N, Cordina R, Corrigan C, Dwyer N, Feenstra J, Horrigan M, Keogh A, Kotlyar E, Lavender M, McWilliams T, Rhodes B, Steele P, Strange G, Thakkar V, Weintraub R, Whitford H, Whyte K, Williams T, Wrobel J, Keating DT. Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing. Heart Lung Circ. 2023 Feb; 32(2):156-165.
-
Galkin A, Sitapara R, Clemons B, Garcia E, Kennedy M, Guimond D, Carter LL, Douthitt A, Osterhout R, Gandjeva A, Slee D, Salter-Cid L, Tuder RM, Zisman LS. Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension. Eur Respir J. 2022 12; 60(6).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|